Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion GroupsGeneral TopicsLow CarbWeightWatchers
WeightAdviser.com
Contact UsLink To UsSearch & Site Map

Weight Loss Forum / General Topics / March 2004

Tip: Looking for answers? Try searching our database.

Dopamine receptors, adenylyl cyclase, and dopamine signaling.

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
Tim - 15 Mar 2004 21:51 GMT
Dopamine activates adenylyl cyclase via D1 receptors and inhibits
activity by D2. 6-OHDA, a neurotoxin, results in cell atrophy and
increased dopamine signaling in surviving neurons, at least in the
nigrostriatal pathway. Cause or effect in CR?

Biochem Pharmacol. 1992 Jul 7;44(1):73-82.  Related Articles, Links  

Dissociation of the striatal D-2 dopamine receptor from adenylyl
cyclase following 6-hydroxydopamine-induced denervation.

Thomas KL, Rose S, Jenner P, Marsden CD.

Parkinson's Disease Society Experimental Research Laboratories, King's
College London, U.K.

Intracellular cyclic AMP accumulation following exposure to dopamine
(DA) agonists and and antagonists was measured in striatal slices from
rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the
nigrostriatal pathway and which showed contralateral circling to
apomorphine. Both DA (10-320 microM) and the D-1 agonist SKF 38393
(0.1-32 microM) increased cyclic AMP accumulation in striatal slices
from the lesioned and intact hemispheres. The EC50 for DA to increase
cyclic AMP accumulation in slices was greater in the 6-OHDA-lesioned
striata compared to the intact striatum, but the EC50 for SKF 38393
was not affected. The D-1 antagonist SCH 23390 (10 microM) completely
inhibited the ability of DA and SKF 38393 to increase cyclic AMP
accumulation in striatal slices from both denervated and intact sides
of the brain. In slices from the intact hemisphere the increase in
DA-induced cyclic AMP accumulation was enhanced by the D-2 antagonist
(+/-)-sulpiride (50 microM) but (+/-)-sulpiride had no effect on the
DA response in slices from the lesioned side. Similarly, the ability
of SKF 38393 to enhance cyclic AMP accumulation was blocked by the D-2
agonist quinpirole (10 microM) in striatal slices from the intact
hemisphere but not in tissue from the lesioned side. The density of
striatal D-1 and D-2 receptors assessed by [3H]SCH 23390 and
[3H]spiperone binding did not differ between the hemispheres although
there was an increase in the affinity of D-1 receptors for [3H]SCH
23390 in the lesioned striatum. After striatal deafferentiation there
appears to be an uncoupling of the "inhibitory" D-2 receptor from the
D-1 receptor-associated adenylyl cyclase.

PMID: 1321630 [PubMed - indexed for MEDLINE]

Tim
Tim - 17 Mar 2004 22:39 GMT
The age-related loss of the D2 dopamine receptor is considered a very
robust biomarker of aging.

Ann Neurol. 1998 Jul;44(1):143-7.  Related Articles, Links  

Parallel loss of presynaptic and postsynaptic dopamine markers in
normal aging.

Volkow ND, Wang GJ, Fowler JS, Ding YS, Gur RC, Gatley J, Logan J,
Moberg PJ, Hitzemann R, Smith G, Pappas N.

Medical Department, Brookhaven National Laboratory, Upton, NY 11973,
USA.

Aging of the human brain is associated with a decline in dopamine (DA)
function, generally interpreted as reflecting DA cell loss. Positron
emission tomography studies revealed that in healthy individuals, the
age-related losses in DA transporters (presynaptic marker) were
associated with losses in D2 receptors (postsynaptic marker) rather
than with increases as is known to occur with DA cell loss. This
association was specific for DA synaptic markers, because they were
not correlated with striatal metabolism. Furthermore, the association
was independent of age, suggesting that a common mechanism regulates
the expression of receptors and transporters irrespective of age.

Publication Types:
Clinical Trial

PMID: 9667606 [PubMed - indexed for MEDLINE]

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9
014455&dopt=Abstract


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7
777135&dopt=Abstract


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2
381502&dopt=Abstract


Tim
Ignoramus5568 - 17 Mar 2004 23:51 GMT
> The age-related loss of the D2 dopamine receptor is considered a very
> robust biomarker of aging.

I wonder if loss of dopamine accounts for less full perception of
life as people age. When I was a kid, grass was greener, sun was
brighter, etc.

i
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2012 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.